1/73
Looks like no tags are added yet.
lung cancer
forms in parenchyma or within bronchi
what is the leading cause of cancer deaths in both men and women
lung cancer 14% of diagnosis’s and 27% of deaths
5 year survival rates lung cancer
15 % average
18% NSCLC
6%SCLC
average age of diagnosis for lung cancer :
70
2/3 of diagnosed ar over 65
what race is most likely to develop lung cancer
African american males
tabacco cause how much lung cancer
80-90% of lung cancer cases a deaths are attributed to smoking
how do we quantify smoking
pack years = pass prepay x years smoked
anything over 1 pack year is considered : SIGNIFICANT TOBACCO EXPOSURE
worse will long duration, unfilled, increased number
Chewing tobacco caused what type of cancers
H&N
second hand smoking and lung cancer
spouse of smoker has 30% increased risk
3rd most common cause of lung cancer
metals that cause lung cancer
nickel silver lchromium, aluminum
asbestos
mesothelioma
radon gas
2nd leading cause of lung cancer
personal and family history leading to lung cancers
history of lung disease causes chronic inflammation
genetic syndroms
Li-Fraumeni syndrom
EDGR pathogenic varients
BRCA 2
local disease symptoms
cough
wheezing
hemoptysis
change in pulmonary habits
chest pain
Regional disease symptoms
chest pain
cough
dyspnea
dysphagia
SVC syndrom - right side lesions
Hoarseness- left sided lesions
Pancoast tumors
Located in apex of lung
cervical and thoracic lymph nodes
must have pain in shoulder and down arm (tumor extension in brachial plexus and erosion of rib 1 and 2)
hand muscle weakness
horners syndrom
Horners Syndrom
Cervical sympathetic nerves involved
Ipsilateral meiosis
Ptosis
Anhydrosis
Enophthalmos
who is screened for lung cancer
55-74 caps at 80 with a 30 pack year history
biopsies for tissue samples
brochocopic needle biopsy
CT guided percutaneous fine needle aspiration for peripheral lesions
mediastinoscopy
lab studies
sputum cytology
Blood and serum chemistry levels
which detection of advanced lung cancer what other scan should be performed
CT or mRI because SCLC and Adenocarcinomas spread to the brain early
Tumor marker for NSCLS
CEA : elevated enough to detect but not specific enough to screen
types:
SCLC 15%
NSCLC: majority
squamous (some)
nonsquamous
Large cell carcinoma
adenocarcinoma(most common)
Small cell Lung cancer
oat cell
CENTRAL REGIONS
3-5% 3 year survival
brain metastesis
only 10% diagnosed with local disease
almost always cigarette caused
Adenocarcinoma
Peripheral regions
likely to distant met lung liver kidney bone
never smokers
women more
most common form in us
squamous cell carcinoma
central in proximal bronchi
tobacco related
men
Small cell staging
in two tiers
limited:
one sided
one lobe
nearby lymph nodes only
treated with radiation
Extensive
Cancer has spread to other side of chest or areas of the body
non small cell lung cancer staging
Uses traditional TNM (1-4)
Direct extension
tumor cells grow into surrounding tissues
Malignant pleural effusion: tumor grows into visceral pleura
lymphatic spread
early and ofoten
lungs drain medially and superiorly
Ipsilateral hilar nodes 50-60%
mediastinal nodes 40-50%
Supraclavicular nodes 5-30%
N staging with lymph node spread
N1: 10-14
N2: 2-9
N3: supraclavicular node or other side of lung
Superior mediastinal nodes
Superior mediastinal nodes
higher mediastinal
upper partracheal
pre vascular and retrotracheal
lower paratarcheal
aortic nodes
subaortic
para- aortic ascending
Inferior mediastinal nodes
subcarinal
paraoesophagheal
pulmonary ligament
N1 nodes
hilar
inter lobar
lobar
segmental
subsegmental
4 node groups
superior mediastinal
aortic
inferior mediastinal
N1
Hematogenous spread
with multiple organ involvement at distant sites
cervical lymph nodes
adrenal glands
liver
bran
bones
kidneys
other lung
Surgery
FOR NSCLC
primary treatment is surgery w/post operative RT
pneumonectomy
lobeectomy
sementectomy
wedge resection
Prophylactic cranial irradiation
SCLC goes to brain fast and early so we treat before it is clinically evident
25 Gy in 10
30in 10-15
24 in 8
Chemo
Cisplatin with topside(VP-16) or Irinotecan
target therapies with
EGFR
ALK
KRAS
conventional fractionation
180-200 cGy per fraction. 6-8 weeks
hyper fractionation
lower dose per fraction, bid or tid, higher cumulative with standard duration
SBRT
for early stage non surgical cases
central tumors 50 in 5
peripherally located 54in 3
palliative dose
3000-400 in 200-300 dose fx
or 800 in 1 but that needs frequent pretreatment
why fuse with PET
Pet is a lot better at showing which nodes to include in treatment
Treatment portals
designed with a 2cm margin around primary tumor and nodal areas
target volume
allow for breathing motion: for lung tumors there is an additional margin (ITV) between PTV and CTV for internal target volume
traditional fields
AP/PA with elective nodal involvement
upper lobe T
middle lobe J
4000-4500 with laterals to 6500-7000
POP boost will need higher energy due to greater separation and only for tumor that extensively crosses midline
10MV
slope of chest needs a wedge
primary RT
6000-7500
surgery + RT
5000-6500
Chemo + RT
3000-5000
palliation or reoccurrence
3000-5000
preoperative
3000-4500
spinla cord td55
47
heart td55
40
esophagustd55
55
liver td55
30
lung td55
1750
brachial plexus td55
60
skin td55
55
bone marrow td55
25
diet guidlines
food and drink at room temp
eat soft bland food
no acid or spice
sip liquids frequently
mix liquids into food
take pain meds
prognosis
SCLC:
3year 10-15%
NSCLC:
15-20% 5year +
stage
histology
performance status (KPS 100 =independant, 0=dead) (EOCG 0 good 5 dead)
weight loss over 5% over 4-6 months
mesothelioma
unique type of lung cancer that is in pleura
AASBESTOS EXPOSURE
Neoadjuvent chemo with surgery (CISPLATIN AND PEMETREXED
RT palliative
5 year survival 10%
most common focal sign of brain tumor
seizure
which way is the heel of wedge facing in an ap pa lunch treatment
heel is superior
T/D 55 Whole brain
45Gy
MedulloBlastoma tissue
PNET
Glial cell tumors
Pilocytic astrocytoma
GBM
Anaplastic astrocytoma
Horner’s syndrome
Ipsilateral miosis
Ptosis
Enophthalmos
most important prognostic indicator for pt with primary brain tumor
histopathology of tumor
TD55 of Lens
10Gy resulting in cataracts